Deciphering how the GR forms oligomers—through the binding of several subunits—opens a crucial avenue for developing more ...

From industrial robots to self-driving cars, engineers face a common problem: keeping machines steady and predictable. When ...

Drugs to treat inflammatory and autoimmune diseases - such as asthma, psoriasis, rheumatoid arthritis or Chrousos syndrome - ...

Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, ...

This month, the White House announced that it is demolishing its East Wing in a bid to build US President Donald Trump’s new ...

Phase 1 data of first-in-class NBD1 stabilizers, SION-719 and SION-451, demonstrated they were generally well tolerated and exceeded desired pharmacokinetic targets ...

Uppsala, Sweden October 23, 2025. Today, Dicot Pharma announces positive topline results from its phase 2a study of LIB-01 for the treatment of erectile dysfunction. The outcomes demonstrated clinical ...

M Series C adds leading life science investors including Sofinnova Partners, a large long-only global asset management company, a large global ...

One of the most remarkable gifts by the mankind to itself is the Artificial Intelligence. Once a new word, Artificial Intelligence or AI, is the most commonly known term to every household now. AI is ...

Healthcare GCCs are likely to be among the most resilient contributors to a rise in GCC employment, reflecting the demands of ...

The total number of schools affected is unknown, though Canvas reports servicing 40% of all United States K-12 school ...

Unfortunately, the institution of journalism is its own worst enemy in the advocacy process. Lofty ethical principles demand ...